Orange Lutheran Zhang Neg
| Tournament | Round | Opponent | Judge | Cites | Round Report | Open Source | Edit/Delete |
|---|---|---|---|---|---|---|---|
| Loyola | 2 | St Croix ADe | Nathan Russell |
|
|
| |
| Orange Lutheran Invitational | Finals | Brett Fortier | Christine Korsgaard |
|
| ||
| Orange Lutheran Invitational | Semis | All Are Allowed | Simply Improve |
|
|
| Tournament | Round | Report |
|---|---|---|
| Loyola | 2 | Opponent: St Croix ADe | Judge: Nathan Russell 1ac - Structural violence |
To modify or delete round reports, edit the associated round.
Cites
| Entry | Date |
|---|---|
0 - Contact InfoTournament: Orange Lutheran Invitational | Round: Finals | Opponent: Brett Fortier | Judge: Christine Korsgaard The best way to contact me is through FB/Phone so try that before email. If you want any disclosure interps met just let me know. Phone: (626)-205-5999 | 8/3/21 |
0 - NavigationTournament: Orange Lutheran Invitational | Round: Semis | Opponent: All Are Allowed | Judge: Simply Improve | 8/3/21 |
1 - CP - Tech TransferTournament: Loyola | Round: 2 | Opponent: St Croix ADe | Judge: Nathan Russell The USFG should:Supply multinational pharmaceutical corporations with generous financial inducements to build vaccine production capacity throughout the worldCreate a network of producers to vaccinate individuals abroadPass legislation that limits shareholder suitsStrip existing patents from companies that do not comply with capacity-building strategies through tech transferKay et. al. 5/13 ~Tamara Kay is a sociologist studying trade, global health and globalization at the Keough School of Global Affairs, University of Notre Dame. Adnan Naseemullah is an international relations scholar at King's College London. Susan Ostermann is a political scientist at the Keough School of Global Affairs, Notre Dame and a former attorney at O'Melveny and Myers LLP, specializing in intellectual property law.) "Waiving patents isn't enough — we need technology transfer to defeat COVID" The Hil, Opinion Contributors: Healthcare, 5/13/21, 2:01 PM EDT, https://thehill.com/opinion/healthcare/553368-waiving-patents-isnt-enough-we-need-technology-transfer-to-defeat-covid?rl=1~~ RM | 9/4/21 |
1 - DA - BioterrorTournament: Loyola | Round: 2 | Opponent: St Croix ADe | Judge: Nathan Russell 1NC – DABiotech is the new frontier; America is ahead but China is dangerously closeGupta 6/11 ~Gaurav Gupta, Biotech Investor, Founder of Ascendant BioCapital, a life science investment firm based in New York. Previously, Gaurav worked at OrbiMed Advisors, and served as a resident in neurological surgery at Columbia University Medical Center. He has co-authored over a dozen articles in peer-reviewed journals, filed a patent on a device for use in spine surgery, and edited a book on the technical and ethical implications of using tissue engineered products in the operating room. Dr. Gupta obtained his M.D. from the Stanford University School of Medicine, where he was a Paul and Daisy Soros Fellow, and B.S. and M.S.E. in biomedical engineering from Johns Hopkins University, where he was a Charles R. Westgate Scholar.) "As Washington Ties Pharma’s Hands, China Is Leaping Ahead" Barron’s Magazine: Commentary, China., 6/11/2021~ RM The plan recapitulates IP to China, destroying competitive advantagesWSJ 5/6 ~Wall Street Journal Editorial Board, WSJ Opinion Philosophy: "We speak for free markets and free people, the principles, if you will, marked in the watershed year of 1776 by Thomas Jefferson's Declaration of Independence and Adam Smith's "Wealth of Nations." So over the past century and into the next, the Journal stands for free trade and sound money; against confiscatory taxation and the ukases of kings and other collectivists; and for individual autonomy against dictators, bullies and even the tempers of momentary majorities." Edited by Paul A. Gigot and Daniel Henninger, "Biden’s Vaccine IP Debacle: His patent heist is a blow to the Covid fight and U.S. biotech." The WSJ Opinion: Review and Outlook, May 6, 2021~ RM China will leapfrog the US through biotech primacyCumbers 20 ~John Cumbers, "I am the founder and CEO of SynBioBeta, the leading community of innovators, investors, engineers, and thinkers who share a passion for using synthetic biology to build a better, more sustainable universe. I publish the weekly SynBioBeta Digest, host the SynBioBeta Podcast, and wrote "What’s Your Biostrategy?", the first book to anticipate how synthetic biology is going to disrupt virtually every industry in the world. I also founded BetaSpace, a space settlement innovation network and community of visionaries, technologists, and investors accelerating the industries needed to sustain human life here and off-planet. I’ve been involved with multiple startups, I am an operating partner and investor at the hard tech investment fund Data Collective, and I'm a former bioengineer at NASA. I earned my PhD in Molecular Biology, Cell Biology, and Biochemistry from Brown University and am originally from the UK.") "China’s Plan To Beat The U.S. In The Trillion-Dollar Global Bioeconomy" Forbes, 2/3/2020~ RM Heg solves arms races, land grabs, rogue states, and great power warBrands 18 ~Hal, Henry Kissinger Distinguished Professor at Johns Hopkins University's School of Advanced International Studies and a senior fellow at the Center for Strategic and Budgetary Assessments." American Grand Strategy in the Age of Trump." Page 129-133~ | 9/4/21 |
1 - DA - InnovationTournament: Loyola | Round: 2 | Opponent: St Croix ADe | Judge: Nathan Russell 1NC – DABiotech RandD is set for high growth and investment nowNASDAQ 8/9 ~NASDAQ is a stock market index that includes almost all stocks listed on the Nasdaq stock exchange. Along with the Dow Jones Industrial Average and SandP 500, it is one of the three most-followed stock market indices in the United States. This article was written by NASDAQ contributors and published on CNBC. The editorial staff of CNBC did not contribute to the creation of this study.) "Why the Nasdaq Biotechnology Index is poised for a run of sustainable growth" CNBC, NASDAQ, 8/9/2021, https://www.cnbc.com/advertorial/2021/08/09/why-the-nasdaq-biotechnology-index-is-poised-for-a-run-of-sustainable-growth-.html~~ RM IPR protections are key to sustain healthcare investments and manufacturing. Independently, it’s key to broader vaccine production.Roberts 6/25/21 ~James M. Roberts is a Research Fellow for Economic Freedom and Growth at the Heritage Foundation. Roberts' primary responsibility as one of The Heritage Foundation's lead experts in economic freedom and growth is to edit the Rule of Law and Monetary Freedom sections of Index of Economic Freedom. An influential annual analysis of the economic climate of countries throughout the world, the Index is co-published by Heritage and The Wall Street Journal.) "Biden’s OK of Global Theft of America’s Intellectual Property is Wrong, Dangerous." 6/25/2021, The Heritage Foundation, Commentary—Public Health~ RM COVID was a precursor to deadlier pandemics—vaccine production will determine everything.Lander 8/4/21 ~Eric Lander, President Biden’s Science Advisory and Director of the White House Office of Science and Technology Policy) "Opinion: As bad as Covid-19 has been, a future pandemic could be even worse—unless we act now" 8/4/21, The Washington Post~ RM Ecosystem sensitivity from climate change means future pandemics will cause extinction—assumes COVIDSupriya 4/19 ~Lakshmi Supriya got her BSc in Industrial Chemistry from IIT Kharagpur (India) and a Ph.D. in Polymer Science and Engineering from Virginia Tech (USA). She has more than a decade of global industry experience working in the USA, Europe, and India. After her Ph.D., she worked as part of the RandD group in diverse industries starting with semiconductor packaging at Intel, Arizona, where she developed a new elastomeric thermal solution, which has now been commercialized and is used in the core i3 and i5 processors. From there she went on to work at two startups, one managing the microfluidics chip manufacturing lab at a biotechnology company and the other developing polymer formulations for oil extraction from oil sands. She also worked at Saint Gobain North America, developing various material solutions for photovoltaics and processing techniques and new applications for fluoropolymers. Most recently, she managed the Indian RandD team of Enthone (now part of MacDermid) developing electroplating technologies for precious metals.) "Humans versus viruses - Can we avoid extinction in near future?" News Medical Life Sciences, 4/19/21, https://www.news-medical.net/news/20210419/Humans-versus-viruses-Can-we-avoid-extinction-in-near-future.aspx~~ RM | 9/4/21 |
Open Source
| Filename | Date | Uploaded By | Delete |
|---|